Immunopathology of secondary-progressive multiple sclerosis

被引:320
作者
Prineas, JW
Kwon, EE
Cho, ES
Sharer, LR
Barnett, MH
Oleszak, EL
Hoffman, B
Morgan, BP
机构
[1] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Newark, NJ 07103 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol, Newark, NJ 07103 USA
[4] Vet Adm Med Ctr, E Orange, NJ 07019 USA
[5] Fels Inst, Philadelphia, PA USA
[6] Temple Univ, Sch Med, Philadelphia, PA 19122 USA
[7] Univ Wales Coll Med, Dept Med Biochem, Cardiff CF4 4XN, S Glam, Wales
关键词
D O I
10.1002/ana.1255
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Twenty-three plaques obtained at early autopsy from 2 patients with secondary-progressive multiple sclerosis were examined immunohistochemically for microglia/macrophages, and for immunoglobulins and components of activated complement. Most of the lesions examined in both cases exhibited evidence of low-grade active demyelination of an unusual type (frustrated phagocytosis) in periplaque white matter. This included linear groups of microglia engaging short segments of disrupted myelin that were associated with deposits of C3d, an opsonin formed during complement activation. Similar microglia/C3d/myelin profiles were not observed in newly forming lesions in cases of acute multiple sclerosis or other central white matter diseases. As C3d coupling is known to increase the immunogenicity of potential antigens enormously, present findings point to disrupted myelin close to plaques as a possible source of the putative multiple sclerosis antigen. Ongoing myelin destruction found in a high proportion of old, established plaques was surprising. It suggests that slowly expanding lesions (progressive plaques), in which ongoing myelin breakdown occurs in the absence of florid perivascular cell cuffing or other histological signs of acute inflammation, contribute to disease progression in cases of secondary-progressive multiple sclerosis..
引用
收藏
页码:646 / 657
页数:12
相关论文
共 72 条
[1]  
AARLI JA, 1975, IMMUNOLOGY, V28, P171
[2]   USE OF PROTON MAGNETIC-RESONANCE SPECTROSCOPY FOR MONITORING DISEASE PROGRESSION IN MULTIPLE-SCLEROSIS [J].
ARNOLD, DL ;
RIESS, GT ;
MATTHEWS, PM ;
FRANCIS, GS ;
COLLINS, DL ;
WOLFSON, C ;
ANTEL, JP .
ANNALS OF NEUROLOGY, 1994, 36 (01) :76-82
[3]   THE LONGSTANDING MS LESION - A QUANTITATIVE MRI AND ELECTRON-MICROSCOPIC STUDY [J].
BARNES, D ;
MUNRO, PMG ;
YOUL, BD ;
PRINEAS, JW ;
MCDONALD, WI .
BRAIN, 1991, 114 :1271-1280
[4]   Axonal pathology in myelin disorders [J].
Bjartmar, C ;
Yin, XH ;
Trapp, BD .
JOURNAL OF NEUROCYTOLOGY, 1999, 28 (4-5) :383-395
[5]   Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions [J].
Bo, L ;
Peterson, JW ;
Mork, S ;
Hoffman, PA ;
Gallatin, WM ;
Ransohoff, RM ;
Trapp, BD .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (10) :1060-1072
[6]  
BRUCK W, 1990, ACTA NEUROPATHOL, V80, P415
[7]   MONOCYTE-MACROPHAGE DIFFERENTIATION IN EARLY MULTIPLE-SCLEROSIS LESIONS [J].
BRUCK, W ;
PORADA, P ;
POSER, S ;
RIECKMANN, P ;
HANEFELD, F ;
KRETZSCHMAR, HA ;
LASSMANN, H .
ANNALS OF NEUROLOGY, 1995, 38 (05) :788-796
[8]   COMPLEMENT POTENTIATES THE DEGRADATION OF MYELIN PROTEINS BY PLASMIN - IMPLICATIONS FOR A MECHANISM OF INFLAMMATORY DEMYELINATION [J].
CAMMER, W ;
BROSNAN, CF ;
BASILE, C ;
BLOOM, BR ;
NORTON, WT .
BRAIN RESEARCH, 1986, 364 (01) :91-101
[9]   The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution [J].
Cuzner, ML ;
Gveric, D ;
Strand, C ;
Loughlin, AJ ;
Paemen, L ;
Opdenakker, G ;
Newcombe, J .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (12) :1194-1204
[10]   Biochemistry of demyelination [J].
Cuzner, ML ;
Norton, WT .
BRAIN PATHOLOGY, 1996, 6 (03) :231-242